UP!
 |
|
|
Type
|
Public company |
|---|---|
| Traded as | NASDAQ: GNVC |
| Industry | Pharmaceuticals |
| Headquarters | Gaithersburg, Maryland, United States |
|
Key people
|
Douglas J. Swirsky, President and CEO |
| Products | CGF166 |
|
Net income
|
 |
|
Number of employees
|
13 |
| Website | www.genvec.com |
GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company working to build a pipeline of therapeutics and vaccines based on its adenovector technology platform that can realize the promise of gene-based medicine. The company's lead product candidate for hearing loss and balance disorders, partnered with Novartis, is in a first-in-man gene delivery Phase 1/2 clinical trial in patients with severe to profound hearing loss. GenVec therapeutics and vaccines have been administered to over 3,000 clinical study subjects.
| 2016-06-20 | Reiterated Rating | Rodman & Renshaw | Buy | $2.30 |
| 2016-05-03 | Reiterated Rating | HC Wainwright | Buy | |
| 2016-03-10 | Lower Price Target | HC Wainwright | Buy | $9.00 to $5.00 |
| 2015-11-05 | Reiterated Rating | HC Wainwright | Buy | |
| 2015-03-26 | Reiterated Rating | HC Wainwright | Buy | $9.00 |
| 2015-01-09 | Set Price Target | Roth Capital | Buy | $8.00 |
| 2014-02-24 | Initiated Coverage | HC Wainwright | Buy | $9.00 |
| 2014-01-24 | Initiated Coverage | Roth Capital | Buy | $8.00 |
| 2016-06-20 | Reiterated Rating | Rodman & Renshaw | Buy | $2.30 |
| 2016-05-03 | Reiterated Rating | HC Wainwright | Buy | |
| 2016-03-10 | Lower Price Target | HC Wainwright | Buy | $9.00 to $5.00 |
| 2015-11-05 | Reiterated Rating | HC Wainwright | Buy | |
| 2015-03-26 | Reiterated Rating | HC Wainwright | Buy | $9.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In GNVC 3 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 80123 |
| BLACKROCK ADVISORS LLC | 826 |
| BlackRock Fund Advisors | 448 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| RUCH JOSHUA | 19.56% (3378410) | GNVC / |
| EcoR1 Capital, LLC | 5.57% (962055) | GNVC / |
| MMCAP International Inc. SPC | 1.49% (257272) | GNVC / NSPH / |
| HOROVITZ ZOLA P | 0.47% (80757) | BCRX / GNVC / PTN / |
| Thornton Mark Owens Sr. Vice President | 0.46% (80000) | GNVC / |
| FISCHER PAUL H Chief Executive Officer | 0.30% (51413) | GNVC / |
| Rooney Kevin M | 0.04% (7500) | GNVC / |
| CONNOR EDWARD M | 0.01% (2500) | GNVC / |
UM